Bcg Immunotherapy of Bladder Cancer

Lamm, Donald L.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 2R01CA027922-05A1
• Application #: 3167887
• Study Section: Experimental Therapeutics Subcommittee 2 (ET)
• Project Start: 1980-04-01
• Project End: 1985-06-30
• Budget Start: 1984-12-01
• Budget End: 1985-06-30
• Support Year: 5
• Fiscal Year: 1985

Institution

• Name: University of Texas Health Science Center San Antonio
• Type: Schools of Medicine
• DUNS #: 800772162
• City: San Antonio
• State: TX
• Country: United States
• Zip Code: 78229

Publications

Lamm, D L; Riggs, D R; Shriver, J S et al. (1994) Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol 151:21-6

Lamm, D L; DeHaven, J I; Shriver, J et al. (1991) Prospective randomized comparison of intravesical with percutaneous bacillus Calmette-Guerin versus intravesical bacillus Calmette-Guerin in superficial bladder cancer. J Urol 145:738-40

Lamm, D L; DeHaven, J I; Shriver, J et al. (1990) A randomized prospective comparison of oral versus intravesical and percutaneous bacillus Calmette-Guerin for superficial bladder cancer. J Urol 144:65-7

Mori, K; Neal Jr, D E; Lamm, D L (1986) Immunological assessment of renal cancer patients as evaluated by the lymphocyte adherence inhibition test. J Urol 136:571-5

Rockwood, A P; Mori, K; Lamm, D L (1986) Serum lymphocyte adherence inhibition test in bladder cancer patients. J Urol 136:1009-12

Lamm, D L (1985) Bacillus Calmette-Guerin immunotherapy for bladder cancer. J Urol 134:40-7